Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem

Technology Drives the Future of Travel: JETOUR Continues to Expand Its "Travel+" Ecosystem

WUHU, China, Oct. 24, 2026 /PRNewswire/ — Expectations for travel are evolving:…

Likang Life Sciences Showcases Personalized Cancer Immunotherapy and Global Ambitions at Abu Dhabi Future Health Summit 2026

BEIJING, Oct. 24, 2026 /PRNewswire/ — Likang Life Sciences ("Likang"), a biotechnology…
Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

Phase II Results of Sacituzumab Tirumotecan (sac-TMT) plus Pembrolizumab in Advanced Urothelial Carcinoma Presented at 2026 ESMO

CHENGDU, China, Oct. 24, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.…
2026 China Marine Economy Expo Kicks Off: Embarking Together on a Journey Toward Digital and Smart Ocean

2026 China Marine Economy Expo Kicks Off: Embarking Together on a Journey Toward Digital and Smart Ocean

SHENZHEN, China, Oct. 24, 2026 /PRNewswire/ — On October 22, Shenzhen World Exhibition…
ASTRI Showcases Pioneering Technologies at InnoCarnival 2026

ASTRI Showcases Pioneering Technologies at InnoCarnival 2026

Driving Technology Adoption, Shaping a Vision for the Future HONG KONG, Oct.…
HKAGE Showcases Gifted Students' Learning Journeys at InnoCarnival 2026

HKAGE Showcases Gifted Students' Learning Journeys at InnoCarnival 2026

Promoting "Technology for Good" Through Innovation and Creativity  HONG KONG, Oct. 24,…
19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event

19th EU-China Business Meeting Concludes! Third-Generation Triple-Helix Biomimetic Collagen Medical Devices Make Their Global Debut, Highlights from the Event

CHENGDU, China, Oct. 24, 2026 /PRNewswire/ — At the 19th EU-China Business…
Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development

Research Will Use Lunit’s AI-powered Pathology Platform to Analyze H&E Whole-Slide Images…